Company intelligence
Airway Innovations, Inc.
Our AERIS Airway® transforms OPAs & NPAs into O2 delivery and CO2 monitoring systems, revolutionizing airway management.
About Airway Innovations, Inc.
At Airway Innovations™, we’re redefining airway management with smarter, safer, and more efficient airway management solutions. Our mission is to empower anesthesia providers with devices that enhance patient safety, simplify workflows, and help healthcare systems deliver better outcomes at lower cost. Innovation in airway management — that’s what drives us. Our first device, the AERIS Airway®, was developed because we believe it is no longer acceptable that hypoxemia remains one of the leading causes of morbidity and mortality during anesthesia care. The AERIS Airway®, transforms oral pharyngeal airways (OPAs) and nasopharyngeal airways (NPAs) into state-of-the-art O2 delivery and ETCO2 monitoring devices.
Verified activity
Signals from Airway Innovations, Inc.
3 published signals
Research & Knowledge
Airway Innovations, Inc. published a clinical study in Anesthesiology News titled Study Finds New Device for Procedural Sedation Delivers Superior Oxygen Concentrations, published in A&A Practice 2026, showing that the AERIS Airway delivered significantly higher oxygen concentrations to the supraglottic space compared with a divided nasal cannula or an oxygen face mask.
Reported by Airway Innovations, Inc.
People
Airway Innovations, Inc. CEO Paul Fehrenbacher has been elected to the AANA Foundation Board of Trustees for a six-year term beginning today.
Reported by Airway Innovations, Inc.
Partnerships
Airway Innovations, Inc. partnered with Anesthesia Service, Inc. to name them the exclusive distributor of the AERIS Airway® across Oklahoma and Texas.
Reported by Airway Innovations, Inc.